David Katz to Aged
This is a "connection" page, showing publications David Katz has written about Aged.
Connection Strength
0.343
-
Ben-Chetrit E, Bnaya A, Barchad OW, Vedder K, Katz DE. Chloramphenicol treatment revisited - demographics, clinical characteristics, and outcomes of hospitalized patients. Eur J Clin Microbiol Infect Dis. 2024 Aug; 43(8):1667-1671.
Score: 0.076
-
Mendlovic J, Zalut T, Munter G, Merin O, Yinnon AM, Katz DE. Mixed effect of increasing outflow of medical patients from an emergency department. Isr J Health Policy Res. 2021 10 27; 10(1):59.
Score: 0.063
-
Mendlovic J, Weiss G, Da'as N, Yinnon A, Katz DE. Internal medicine patients admitted without COVID-19 during the outbreak. Int J Clin Pract. 2020 Dec; 74(12):e13630.
Score: 0.058
-
Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. 2019 Apr; 53(4):423-428.
Score: 0.052
-
Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Marchaim D. Diabetic foot infection in hospitalized adults. J Infect Chemother. 2016 Mar; 22(3):167-73.
Score: 0.043
-
Katz DE, Martone WJ. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin. Clin Ther. 2007 Nov; 29(11):2440-7.
Score: 0.024
-
Leibner G, Katz DE, Esayag Y, Kaufman N, Brammli-Greenberg S, Rose AJ. Incorporating clinical and demographic data into the Elixhauser Comorbidity Model: deriving and validating an enhanced model in a tertiary hospital's internal medicine department. BMC Health Serv Res. 2024 Dec 05; 24(1):1523.
Score: 0.020
-
Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009 May; 63(5):1034-42.
Score: 0.007